Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications-Reference-Cited by-同舟云学术

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications

Published:2021-10-11 Issue:12 Volume:62 Page:3016-3028
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Rosenfeld William E.¹^ORCID,Abou‐Khalil Bassel²,Aboumatar Sami³,Bhatia Perminder⁴,Biton Victor⁵,Krauss Gregory L.⁶^ORCID,Sperling Michael R.⁷^ORCID,Vossler David G.⁸^ORCID,Klein Pavel⁹^ORCID,Wechsler Robert¹⁰¹¹^ORCID

Affiliation:

1. Comprehensive Epilepsy Care Center for Children and Adults St. Louis Missouri USA

2. Vanderbilt University Medical Center Nashville Tennessee USA

3. Austin Epilepsy Care Center Austin Texas USA

4. Neuro‐Pain Medical Center Fresno California USA

5. Arkansas Epilepsy Program Little Rock Arkansas USA

6. Johns Hopkins University School of Medicine Baltimore Maryland USA

7. Thomas Jefferson University Philadelphia Pennsylvania USA

8. University of Washington School of Medicine Seattle Washington USA

9. Mid‐Atlantic Epilepsy and Sleep Center Bethesda Maryland USA

10. Consultants in Epilepsy & Neurology PLLC Boise Idaho USA

11. Idaho Comprehensive Epilepsy Center Boise Idaho USA